Cancer informatics for the clinician: An interaction database for chemotherapy regimens and antiepileptic drugs

Seizure

Volumn 19, Issue 1, 2010, Pages 59-67

  Yap, Kevin Yi Lwern ^a   Chan, Alexandre ^a,b   Chui, Wai Keung ^a   Chen, Yu Zong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Anticancer drugs; Antiepileptic drugs; Chemotherapy regimens; Drug interactions; OncoRx database

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; GENERIC DRUG;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; COMPUTER PROGRAM; DATA BASE; DRUG INFORMATION; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; NEOPLASM; ONCOLOGY; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 84983720221     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.11.004     Document Type: Article

References (44)

1. Kaufman D., and Chabner B.A. Clinical strategies for cancer treatment: the role of drugs. In: Chabner B.A., and Longo D.L. (Eds). Cancer chemotherapy and biotherapy: principles and practice (1996), Lippincott-Raven, Philadelphia 1-16
2. Yap T.A., Carden C.P., and Kaye S.B. Beyond chemotherapy: targeted therapies in ovarian cancer. Nature Reviews Cancer 9 (2009) 167-181
3. Kudo M. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 75 (2008) 1-12
4. Matta A., and Ralhan R. Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head and Neck Oncology 1 (2009) 6
5. Lordick F., and Jäger D. Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers. Gastrointestinal Cancer Research 2 (2008) 187-197
6. Herbst R.S., Lynch T.J., and Sandler A.B. Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy. Clinical Lung Cancer 10 (2009) 20-27
7. Yap K.Y.-L., Chui W.K., and Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clinical Therapeutics 30 (2008) 1385-1407
8. Karas Jr. S. The potential for drug interactions. Annals of Emergency Medicine 10 (1981) 627-630
9. Riechelmann R.P., Tannock I.F., Wang L., Saad E.D., Taback N.A., and Krzyzanowska M.K. Potential drug interactions and duplicate prescriptions among cancer patients. Journal of the National Cancer Institute 99 (2007) 592-600
10. Gilbar P.J., and Brodribb T.R. Phenytoin and fluorouracil interaction. Annals of Pharmacotherapy 35 (2001) 1367-1370
11. Newton H.B., Goldlust S.A., and Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. Journal of Neuro-oncology 78 (2006) 99-102
12. Lassman A.B., and DeAngelis L.M. Brain metastases. Neurologic Clinics 21 (2003) 1-23 vii
13. Perucca E. Pharmacologic advantages of antiepileptic drug monotherapy. Epilepsia 38 (1997) S6-S8
14. Patsalos P.N., Fröscher W., Pisani F., and van Rijn C.M. The importance of drug interactions in epilepsy therapy. Epilepsia 43 (2002) 365-385
15. Glantz M.J., Cole B.F., Forsyth P.A., Recht L.D., Wen P.Y., Chamberlain M.C., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000) 1886-1893
16. Elkayam E.S., Sirven J.I., Wingerchuk D.M., Drazkowski J.F., Lyons M.K., and Zimmerman R.S. Seizure prophylaxis and liability. Mayo Clinic Proceedings 80 (2005) 288 and 291
17. Yap K.Y.-L., Chen Y.Z., Chui W.K., and Chan A. Oncoinformatics for the healthcare professional: oncology databases and blogs. Internet Journal of Oncology 6 (2009). http://www.ispub.com/journal/the_internet_journal_of_oncology/volume_6_n umber_1_36/article/oncoinformatics_for_the_healthcare_professional_oncol ogy_databases_and_blogs.html Available from http://www.ispub.com/journal/the_internet_journal_of_oncology/volume_6_n umber_1_36/article/oncoinformatics_for_the_healthcare_professional_oncol ogy_databases_and_blogs.html [accessed 8 October 2009]
18. Bjerrum L., Andersen M., Petersen G., and Kragstrup J. Exposure to potential drug interactions in primary health care. Scandinavian Journal of Primary Health Care 21 (2003) 153-158
19. American Society of Health-System Pharmacists, AHFS Drug Information website, 2008. Available from http://www.ahfsdruginformation.com [accessed 27 May 2009].
20. British Medical Association and Royal Pharmaceutical Society of Great Britain, Digital British National Formulary, 2007. Available from http://www.bnf.org [accessed 27 May 2009].
21. ® ONLINE™, 2007. Available from http://www.lexi.com [accessed 27 May 2009].
22. ® Healthcare Series [internet database]. Available from http://www.micromedex.com [accessed 8 August 2009].
23. British Medical Association and Pharmaceutical Society of Great Britain. British national formulary. 53rd ed. (2007), BMJ Publishing Group Ltd & RPS Publishing, London, UK
24. Lacy C.F., Armstrong L.L., Goldman M.P., and Lance L.L. Drug information handbook with international trade names index. 15th ed. (2007-2008), Lexi-comp Inc., Hudson, OH
25. Solimando D.A.J. Drug information handbook for oncology. 6th ed. (2007), Lexi-comp, Hudson, OH
26. BC Cancer Agency, BCCA cancer drug manual, 2007. Available from http://www.bccancer.bc.ca/HPI/DrugDatabase/default.htm [accessed 8 August 2009].
27. Wishart D.S., Knox C., Guo A.C., Shrivastava S., Hassanali M., Stothard P., et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research 34 (2006) D668-D672
28. Klein T.E., Chang J.T., Cho M.K., Easton K.L., Fergerson R., Hewett M., et al. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenomics Journal 1 (2001) 167-170
29. ® Healthcare Series (version 5.1) [intranet database]. Available from http://www.thomsonhc.com/hcs/librarian/PFPUI/fV1mNyY303TXxR [accessed 8 August 2009].
30. New Dream Network LLC, DreamHost™ web hosting, 1996. Available from http://www.dreamhost.com [accessed 27 May 2009].
31. Neef C., and de Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clinical Pharmacology and Therapeutics 43 (1988) 372-375
32. Ihde D.C., Mulshine J.L., Kramer B.S., Steinberg S.M., Linnoila R.I., Gazdar A.F., et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. Journal of Clinical Oncology 12 (1994) 2022-2034
33. Translational Research Working Group (National Cancer Institute), N.I.H., TRWG definition of translational research, 2007. Available from http://www.nci.nih.gov/trwg/TRWG-definition-and-TR-continuum [accessed 27 May 2009].
34. Johnstone D. Translational science-a sexy title for pre-clinical and clinical pharmacology. Available from http://www.pa2online.org/articles/article.jsp?volume=3&issue=1&a rticle=54 [accessed 27 May 2009].
35. Shortliffe E.H., and Garber A.M. Training synergies between medical informatics and health services research. Journal of the American Medical Informatics Association 9 (2002) 133-139
36. Masys D.R., Brennan P.F., Ozbolt J.G., Corn M., and Shortliffe E.H. Are medical informatics and nursing informatics distinct disciplines? The 1999 ACMI debate. Journal of the American Medical Informatics Association 7 (2000) 304-312
37. Bast Jr. R.C., Mills G.B., and Young R.C. Translational research-traffic on the bridge. Biomedicine and Pharmacotherapy 55 (2001) 565-571
38. Manon-Espaillat R., Burnstine T.H., Remler B., Reed R.C., and Osorio I. Antiepileptic drug intoxication: factors and their significance. Epilepsia 32 (1991) 96-100
39. Marcus R.E., and Goldman J.M. Convulsions due to high-dose busulphan. Lancet 324 (1984) 1463
40. Chan K.W., Mullen C.A., Worth L.L., Choroszy M., Koontz S., Tran H., et al. Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplantation 29 (2002) 963-965
41. Hassan M., Oberg G., Björkholm M., Wallin I., and Lindgren M. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemotherapy and Pharmacology 33 (1993) 181-186
42. Benjamin I., Goldwein J.W., Rubin S.C., and McKenna W.G. OncoLink: a cancer information resource for gynecologic oncologists and the public on the Internet. Gynecologic Oncology 60 (1996) 8-15
43. Adjuvant Inc., Adjuvant Online: decision making tools for health care professionals, 2006. Available from http://www.adjuvantonline.com; [accessed 27 May 2009].
44. Lohr L. Chemotherapy-induced nausea and vomiting. Cancer Journal 14 (2008) 85-93